Whatever happened to the new no-patent COVID vaccine touted as a global game changer?

https://www.npr.org/sections/goatsandsoda/2022/08/31/ [login to see] /whatever-happened-to-the-new-no-patent-covid-vaccine-touted-as-a-global-game-cha
Back in January, we told you about a different kind of COVID vaccine that had just been approved for use in India. The vaccine, called Corbevax, had some very attractive properties: It's low-cost, easy to make using well-established biotech processes — and patent-free.

The vaccine's inventors were hoping it would help address questions of vaccine equity for countries that can't afford to make or buy expensive vaccines like the ones sold by Pfizer and Moderna.